Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Cover Story

Awareness of women’s heart health has increased, but more research, outreach required

FDA News

FDA: Health benefits of St. Jude Medical implantable devices outweigh cybersecurity risks

FDA approves expanded indication for empagliflozin to reduce CV death in type 2 diabetes


2 decades of hypertension

George L. Bakris, MD

In the Journals

Increased conflict of interest policies needed for guideline committees, advocacy organizations

Most patients fail to receive high-potency statins after ACS

New review on dietary sugar guidelines spark debate

Type 2 MI in patients with HIV often caused by unconventional factors

Model helps predict which patients with HF may benefit from ICD

HIV status significantly influences HF outcomes in women

Personal, professional lives of cardiologists vary between sexes

Predictors for discontinuation of warfarin therapy identified

Thrombolysis treatment within 1 hour linked to best outcomes for acute ischemic stroke

Omega-3 fatty acids, dark fish not associated with elevated CVD risk in women

One-year TAVR outcomes superior in women vs. men

Report: Workplace improvements needed for childbearing cardiologists

AHA: With proper management, successful pregnancy feasible for women with complex congenital heart disease

ACE inhibitors slow progression of myocardial fibrosis in patients with muscular dystrophy

ACP, AAFP recommend ‘less aggressive’ systolic BP target for older patients with hypertension

Activity in amygdala predicts CV events

CVD incidence in veterans reduced by lifestyle change program

Alcohol abuse increases CVD risk

Elevated systolic BP, related deaths rose worldwide over 25 years; burden in US high

Industry News

Outcomes after stroke not influenced by sex after adjustment for confounders

Court grants injunction to prevent US sales of alirocumab due to patent infringement

Pharmacology Consult

Drug therapy for managing primary orthostatic hypotension

Genevieve Hale, PharmD, BCPS

Trial Scorecards

Trial Scorecard: TORO

Trial Scorecard: YELLOW II

Trial Scorecard: FREEDOM

Trial Scorecard: AF-CHF

Trial Scorecard: COSM

Trial Scorecard: BVS-EXPAND

Trial Scorecard: SHIELD-2

Trial Scorecard: PSY-HEART

Women's Heart Notes

Matters of the heart and mind

Ki Park, MD, MS, FSCAI